Imaging Studies Support Cognitive Reserve Theory
holds up in older people (age 65 and up) lacking overt memory problems.—Esther Landhuis None
ALL NEWS
373 RESULTS
You searched Landhuis
Sort By:
- Most Recent
- Most Commented
- Most Relevant
ADNI: One-year Data Narrow Field of MRI, FDG-PET Approaches
of the study,” she said.—Esther Landhuis. This is Part 1 of a two-part series. See also Part 2. None
F18 PET Tracers, New MRI Method to Expand Reach of Brain Imaging
ADNI2 participants will get ASL as part of their MRI scan.—Esther Landhuis None
Bad Guys—Aβ Oligomers Live Up to Reputation in Human Studies
story; Gandy et al., 2010).—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2439
Chicago: APP Roles in Caspase Gene Regulation, Muscle Function?
C-terminus—which binds Fe65 and other cytoplasmic proteins—could still mediate key APP functions.—Esther Landhuis
Chicago: Studies Probe Diminishing Placebo Decline, Part 1
Landhuis. This is a two-part story. See also Part 2. None http://www.alzforum.org/new/detail.asp?id=1884
Phosphodiesterase Blockers Boost Memory—Without Nausea?
re-evaluating that decision.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2659
SIRT1, Resveratrol and More: Moving Closer to Anti-aging Elixir?
and geranylgeranylation.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=1874 Aging Sirtuins
Chicago: Nicotinic AChRs: α4β2 Iffy for AD, More Promise With α7?
abstracts.—Esther Landhuis. This is Part 1 of a three-part series. See also Parts 2 and 3. None
Medical Foods—Food for Thought, But Think Twice
their brains are too damaged to be repaired.”—Esther Landhuis. This is Part 2 of a two-part series. See Part 1.
Plasma Markers for Alzheimer’s—Slowly But Surely?
a clinical-grade assay.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3259 Alzheimer's
Wrapping Up Enrollment, ADNI 2, PPMI Focus on Earlier Disease
on the ADNI site.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=3448 Alzheimer's
Therapeutic Approaches Target Deubiquitinase, Protein Turnover
to address these issues.—Esther Landhuis. This is Part 1 of a three-part series. See also Part 2, Part 3.
San Diego: Flexible N-Termini Key to Aβ42 Oligomer Toxicity?
studies.—Esther Landhuis. None http://www.alzforum.org/new/detail.asp?id=2630 Alzheimer's Disease Aβ
Honolulu: Biomarker Profiles That Spell Trouble for ‘Normals’?
Landhuis. None http://www.alzforum.org/new/detail.asp?id=2531 Alzheimer's Disease Biomarkers Clinical